Reminiscence therapy‐based care program relieves anxiety, depression and improvs quality of life in post‐operational non‐small cell lung cancer patients

2021 ◽  
Author(s):  
Meifang Liu ◽  
Yao Li
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Cancer Patients ◽  
Care Program ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Reminiscence Therapy ◽  
Anxiety Depression

Quality of life assesment in patients with non-small cell lung cancer patients who have or have not received second line chemotherapy

2015 ◽  
Vol 48 (2) ◽  
pp. 53-62
Author(s):  
Nuretdin Suna ◽  
Bülent Yalçın ◽  
Ahmet Şiyar Ekinci ◽  
Onur Aydınlı ◽  
Ahmet Demirkazık ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Line Chemotherapy

LuCaS (Lung Cancer Surveillance) study: Surveillance models for advanced lung cancer patients.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e20546-e20546
Author(s):  
Sarah Anne Fraser
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Health Care ◽  
Cancer Patients ◽  
Small Cell ◽  
Advanced Lung Cancer ◽  
Small Cell Lung ◽  
Lung Cancer Patients

e20546 I hope to present the trial protocol as a poster at ASCO with co design work commencing 2017. Background: Lung cancer is the leading cause of cancer death in NZ.1 85% of registrations annually are stage four at diagnosis, presenting a significant burden on resources. Despite novel therapies, survival is poor and quality of life is a key consideration in patient management .2,3 Currently the aim of surveillance is to detect for disease progression and follows a three monthly pattern. There is little literature around benefits of surveillance on survival, and quality of life in these patients. 4-6 Alternative approaches to surveillance should be evaluated to ensure safe, convenient, economical care. Lung cancer outcomes for Maori patients sit significantly lower than those for New Zealand Europeans. Maori patients are twice as likely to present with locally advanced disease and four times less likely to receive curative treatment (multivariate analysis). There are significant barriers for Maori patients to attending health care including time off work, health literacy, costs, child care, language barriers, and transport. 19 Ministry of Health data describes poor outcomes for Maori lung cancer patients with rate of death sitting at 3.4 times that of non-Maori. Co-Primary End Points To determine if there is a reduction in health services utilisation (ED visits, hospital visits, unplanned clinic visits, GP visits, and Nurse Specialist contact) with the end point identified at progression, lost to follow up, or death. To compare the impact of a novel virtual surveillance model (VSM) versus usual follow-up care on patient anxiety measured using the HADS-A tool. Methods: LuCaS is a Randomised Controlled trial in patients with advanced lung cancer randomised to virtual model or standard care. Results: recruitment begins this year. Conclusions: Hypothesis:A virtual follow up model for advanced stage non-small cell lung cancer patients, extensive stage small cell lung cancer patients, and mesothelioma patients will reduce health care utilisation and patient experienced anxiety defined by reduction in Hospital Anxiety and Depression Scale (HADS-A) score, while maintaining effectiveness detecting recurrence and survival.

scholarly journals Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients

2008 ◽  
Vol 19 (8) ◽  
pp. 1458-1464 ◽  
Author(s):  
W. Jacot ◽  
B. Colinet ◽  
D. Bertrand ◽  
S. Lacombe ◽  
M.-C. Bozonnat ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Comorbidity Score ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document